Quintiles issued a mixed set of revised financial predictions for 2013, increasing its earnings per share forecast after a surge of new business wins and narrowing its service revenue.
Sponsor network developer DrugDev on Monday announced it would acquire CFS Clinical, which specializes in managing the financing of clinical trials. Financial terms were not disclosed.
Parexel has teamed up with Japanese trial management services firm Fuijitsu Systems West in an agreement that underlines the CROs eClinical growth ambitions in Asia.
CRO Quintiles says it is in favor of the voluntary sharing of de-identified and masked clinical and preclinical data that protects the interests of research participants and proprietary data, though it stopped short of calling for the public release of...
Cromsource has opened offices in Paris in response to the growth of pharma R&D which is flourishing under French Government incentives, the company says.
CRO sales representatives do a good job of explaining the basics of their service offerings but they need to be more innovative in tackling sponsors’ individual challenges, according to a new survey.
Biofocus says it is literally bringing its scientists closer together to aid its drug discovery services with a new 60,000 square foot facility in Cambridge, UK.
CROs across the board saw revenue increase by more than 10% between 2011 and 2012, which was largely fuelled by Quintiles' growth, according to a new report.
The TransCelerate BioPharma industry group has launched its clinical trial comparator network to establish a reliable means for sourcing quality drugs for clinical trials.
CRO Quintiles last week announced its fourth consecutive quarter of at least $1B in net new business, as well as 13% growth in the second quarter of this year, though analysts said the company did not meet bookings expectations.
The latest survey of clinical trial investigators found almost half most prefer to work with Covance’s central laboratories while nearly a quarter said they preferred Quintiles.
Private equity firm KKR announced today it will acquire RPS (ReSearch Pharmaceutical Services) from Warburg Pincus and will merge the company with PRA International.
The California Institute of Regenerative Medicine’s board signed off on the allocation of $70M to begin setting up clinics and to bring a number of developing stem cell therapies into clinical trials.
WuXiPRA, the new China-based joint venture between the two CROs, has named contract research veteran James Pusey, MD, as president and general manager.
Altasciences’ purchase of Vince and Associates Clinical Research highlights the industry's shift to conducting more specialized Phase I trials in patients rather than healthy volunteers, experts say.
Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from Novella, MicroConstants and Cromos Pharma.
Covance’s 10 percent growth in Q1 2013 compared to the same quarter last year was driven mostly by its central laboratories business and has caused a boost in its revenue targets for the rest of the year.
Bristol-Myers Squibb (B-MS) has signed up Quintiles as a central labs supplier, prompting more questions about Icon’s status as a preferred provider of laboratory services.
Some of largest pharmaceutical, biotech and CRO (contract research organizations) companies are beginning preparations for a summit in May to focus on how to manage quality in the outsourcing of clinical trials.
Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from PPD, Chiltern and Premier Research.
CRO (clinical research organization) employees are switching jobs at dramatically higher rates than their counterparts in other industries, especially overseas, according to a survey on CRO compensation.
Catalent says it has acquired a Chinese softgel producer to expand its drug delivery offerings and expects more investments to come as part of a two-pronged plan into China.
Ireland-based CRO Icon unveiled higher than expected revenue and backlog increases in 2012 when compared to 2011, and the company expects even stronger results in 2013.
Outsourcing-pharma.com readers want the acronym CRO to stand for 'contract research organisation' according to the results of a snap poll we ran yesterday.
Outsourcing-pharma.com witnessed a fascinating debate on the definition of ‘CRO’ yesterday with terms like 'collaboration' and 'release' being suggested as potential alternatives.
UK Government proposals to hand oversight of tissue handling to a non-specialist body would have a negative impact on the preclinical services sector says the Human Tissue Authority.
